Newsroom

Publications
Étude Fièvre Jaune

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Read more
UneEN-Sica
Vidéos
Antibiogo

Antibiogo : Routine implementation within the MSF Sica Laboratory in Bagui, CAR

UneAi4CC_video
Vidéos
AI4CC

Cervical cancer: detect better, detect earlier with the help of AI, report in Malawi

Articles
AI4CC

Cervical cancer : when AI helps improve diagnosis

Cervical cancer is the second deadliest cancer in low- and middle-income countries (1). In Malawi in East Africa, where MSF operates, over 4,000 Malawian women fall sick with cervical cancer every year. With 2,905 deaths due to cervical cancer in 2020, the country also had the second highest rate of mortality (2). How can we explain such a high mortality rate from this disease which, in high-income countries, is easily preventable and generally less deadly?  The reasons include limited access to prevention and screening, and diagnoses that are not always reliable.

 

Clara Nordon, Director of the MSF Foundation, has just got back from a visit to Malawi with the MSF teams and tells us about the project led by the Foundation. Code name: AI4CC

Read more
IrakExploEn_une
Vidéos
Programme 3D

The MSF Foundation is exploring patient follow-up possibilities in Baghdad and northern Iraq

UneMotionAntibiogo
Vidéos
Antibiogo

All about Antibiogo, a free application to counter AMR

Headline

A day at Blantyre cervical cancer referral hospital
Articles
Développement de l'offre de rééducation

Rehabilitation after cervical cancer treatment in Malawi: how can access for patients be improved?

In Malawi, many women treated for cervical cancer travel long distances to access rehabilitation care, even though it is essential for their recovery. In Blantyre, as part of MSF’s cervical cancer prevention and treatment programme, the MSF Foundation has been developing and supporting a specialised rehabilitation service for women for the past two years. Today, it is working to decentralise this care to make it more accessible. 

Cervical cancer remains a major public health issue in Malawi. The country has one of the highest prevalence rates in the world: nearly 40% of cancers diagnosed in women are cervical cancer, and the disease causes around 3,000 deaths every year. 

Read more

MSF Foundation in Video

News

Publications

  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.